Cannabis and Insomnia

Not medical advice

This article is not medical advice. It summarizes published evidence as of writing. Insomnia can be a symptom of serious underlying conditions (sleep apnea, depression, thyroid disease, medication side effects). Talk to a clinician before self-treating chronic sleep problems with cannabis or anything else. If you are pregnant, under 25, have a history of psychosis, or take other sedating medications, the calculus changes significantly.

Plain-language summary

Most people who use cannabis to sleep report falling asleep faster. That short-term effect is real and supported by small clinical studies and decades of patient reports ^[1][2]. The catches:

• Tolerance builds quickly. Within days to weeks of nightly use, the sleep-onset benefit fades ^[3].
• THC suppresses REM sleep. This is a consistent lab finding ^[4]. Whether that matters clinically for healthy adults is debated; for people with PTSD nightmares it may actually be desirable.
• Stopping causes rebound insomnia. Sleep gets noticeably worse for days to weeks after heavy users quit ^[5]. This is one of the most reliable signs of cannabis withdrawal.
• CBD alone is unimpressive for insomnia at the doses sold in most consumer products ^[6].
• CBN — the 'sleep cannabinoid' — has essentially no controlled human evidence supporting sedation ^[7]. The marketing is far ahead of the science.

For chronic insomnia, the first-line treatment is Cognitive Behavioral Therapy for Insomnia, not any drug.

What probably works

Short-term reduction in time to fall asleep with THC-dominant cannabis. Weak / limited Multiple small trials and a large body of patient self-report data show THC at low-to-moderate doses (roughly 2.5–15 mg oral, or equivalent inhaled) reduces sleep latency ^[1][2][8]. This is the most robust sleep finding for cannabis, though 'robust' here means consistent small studies, not large RCTs.

Improved sleep in patients with chronic pain. Weak / limited When pain is the thing keeping you awake, reducing pain helps you sleep. Trials of nabiximols (Sativex) and other cannabinoid preparations in chronic pain populations show secondary improvements in sleep ^[9]. This is an indirect benefit — the cannabis is treating pain, and better pain control yields better sleep.

Reduction of PTSD-related nightmares with synthetic cannabinoids. Weak / limited Nabilone has small-trial evidence for reducing nightmare frequency in PTSD ^[10]. This is a specific use case, not general insomnia.

What might work

CBD at high doses (300+ mg). Weak / limited A few small studies suggest CBD at higher doses may help anxiety-driven insomnia ^[6][11]. The doses used in research are typically far above what's in a 25 mg gummy. At consumer-product doses (10–50 mg), evidence is essentially absent.

THC:CBD combinations. Weak / limited Some patients report better sleep with mixed products than pure THC, possibly because CBD blunts THC anxiety. Trial data is limited and mixed.

Microdosing oral THC (1–2.5 mg) for older adults. Weak / limited Some observational data from medical cannabis programs in Israel and Canada suggest low-dose oral THC improves sleep in elderly patients with relatively few side effects ^[12]. Promising but not definitive.

What doesn't work or has weak evidence

CBN as a sleep aid. No data CBN is marketed aggressively as 'the sleep cannabinoid.' The origin of this claim is a single 1975 study with five subjects that combined CBN with THC and could not separate their effects ^[7]. No controlled trial since has shown CBN alone is meaningfully sedating in humans. It is folklore with a price tag.

'Indica' strains for sleep. Disputed The indica/sativa distinction does not reliably predict chemistry or effects ^[13]. A strain labeled 'indica' may have a chemical profile indistinguishable from a 'sativa.' Effects depend on cannabinoid and terpene content, not the marketing category.

Myrcene as a sedative ('the couch-lock terpene'). Weak / limited The popular claim that strains over 0.5% myrcene are sedating has no clinical basis. Myrcene has mild sedative effects in rodent studies at doses far above what you'd inhale from cannabis ^[14]. Folklore.

Long-term nightly use for chronic insomnia. Weak / limited Tolerance to the sleep-onset effect develops within weeks ^[3]. Heavy chronic users often have worse objective sleep than non-users ^[15].

What we don't know

• Whether chronic REM suppression from nightly THC has long-term cognitive consequences in healthy adults.
• Optimal dosing — almost all consumer products are dosed by tradition, not trial data.
• Whether minor cannabinoids (CBN, CBC, THCV) have any sleep-relevant pharmacology in humans at realistic doses.
• How cannabis interacts with common sleep medications (z-drugs, trazodone, melatonin) — there is very little co-administration data.
• Long-term outcomes. Most cannabis-and-sleep trials are weeks long. Insomnia is often a years-long problem.

Comparison with standard treatments

CBT-I (cognitive behavioral therapy for insomnia) is the recommended first-line treatment for chronic insomnia by the American College of Physicians and most international guidelines ^[16]. It outperforms every drug in long-term outcomes and has no side effects. It is underused because it requires effort and access to a trained therapist or a good app.

Z-drugs (zolpidem, eszopiclone) work faster than cannabis for sleep onset but carry risks of dependence, complex sleep behaviors, and next-day impairment.

Trazodone is widely prescribed off-label for sleep with modest evidence.

Melatonin has good evidence for circadian rhythm disorders and modest evidence for general insomnia, with an excellent safety profile.

Cannabis sits in an awkward spot: better evidence than many supplements, worse evidence than prescription hypnotics, and far worse evidence than CBT-I. Its main practical advantages are accessibility and a perception of being 'natural.' Neither is a clinical argument.

Risks

• Tolerance and dependence. Daily users often need escalating doses and experience Cannabis Withdrawal — including severe rebound insomnia — when stopping ^[5].
• REM rebound. After stopping chronic use, REM sleep returns aggressively, often with vivid dreams or nightmares lasting weeks.
• Next-day grogginess, especially with high-THC edibles taken late.
• Worsened anxiety at high THC doses, which can itself sabotage sleep.
• Drug interactions, particularly with other CNS depressants (alcohol, benzodiazepines, opioids).
• Cardiovascular load from acute THC, relevant for people with heart disease.
• Psychosis risk in vulnerable individuals, particularly young people and those with personal or family history ^[17].
• Masking underlying conditions. Using cannabis to sleep can hide untreated sleep apnea, depression, or other disorders that need actual diagnosis.

Practical bottom line

If you occasionally can't sleep, low-dose THC (2.5–5 mg oral, or a few inhalations) is a reasonable short-term tool — better evidence than CBN or melatonin, worse than CBT-I. If you find yourself using it every night for months, you have crossed into a use pattern where the evidence does not support continued benefit and the withdrawal cost on quitting will be real. For chronic insomnia, do CBT-I. Everything else is a stopgap.

Sources

How this page was made

Related

• Cannabis and PTSD — What the evidence actually says about using cannabis to treat post-traumatic stress disord...
• Myrcene — The most common monoterpene in cannabis, blamed and credited for a lot of things it probab...